HomeOpen Access NewsHealth & Social Care

Health & Social Care

Benefit cuts will worsen mental health crisis for low-income people

Mental health charity Mind warns that cutting benefits will deepen the mental health crisis for people on low incomes.

How valuable are randomised controlled trials in reproductive medicine?

Professor Darren Griffin reflects on how patients in fertility clinics should interpret the scientific evidence base when even the experts can’t seem to agree.

Bharat Biotech COVID vaccine shows 81% efficacy at Phase Three

The Bharat Biotech COVID vaccine, COVAXIN, appears to be 81% efficient against the virus in Phase Three of clinical trials.

COVID vaccines for mutations will be given faster approval in the UK

Medical regulators will fast-track COVID vaccines for mutations, similar to how seasonal flu shots are developed and released.

Are swollen lymph nodes normal after getting the COVID vaccine?

According to radiologists at Massachusetts General Hospital (MGH), swollen lymph nodes after COVID vaccination are a "normal reaction that typically goes away with time".

Japanese scientists are creating realistic steak meat in a petri dish

A team at the University of Tokyo are creating steak meat in a petri dish, which could soon become the most realistic tasting biosynthetic meat available.

The AstraZeneca vaccine is atleast 60% effective for people aged 70 and over

A study examining older people in the UK found that only one dose of the AstraZeneca vaccine is atleast 60% effective for people aged 70 and over.

Researchers investigate the genetics of eating disorders

An international research team have discovered that the genetics of eating disorders and some psychiatric disorders have some similarities, raising new questions about treatment for both.

Scientists find that elevated neutrophils can predict severe COVID and death

Researchers at Yale believe that blood tests could predict severe or critical COVID cases, because blood holds a series of interesting biological signals about a person.

FDA approves the Johnson & Johnson vaccine for use

The US Food and Drug Administration (FDA) approved the Johnson & Johnson vaccine, with an efficacy of 86%, as the next to be rolled out across the US.

The Brazilian COVID mutation has been found in the UK

The UK has found six confirmed cases of the Brazilian COVID mutation yesterday (28 February) - but an individual who tested positive three weeks ago is still being traced throughout the country.

45% of people living with obesity have healthy blood pressure

Scientists have discovered that up to 45% of people living with obesity have healthy blood pressure, glucose and lipid levels - protecting them from the risk of cardiovascular disease.

Arthritis impacts six million Canadians and counting

Dr Siân Bevan, Chief Science Officer of the Arthritis Society describes how arthritis impacts six million Canadians and counting.

The window for convalescent plasma donation is just under two months

New data suggests that before 60 days of COVID symptoms beginning is the best window for convalescent plasma donation - which is how antibodies were created in countless COVID-19 patients before vaccines.

What are the priority groups for phase two of UK vaccinations?

The Government unveiled the confirmed priority groups for phase two of UK vaccinations - the Joint Committee on Vaccination and Immunisation (JCVI) is choosing age as the deciding factor.

1.17 million doses of the AstraZeneca vaccine could expire in Germany

Germans have only taken 270,986 AstraZeneca doses so far, leaving roughly 1.17 million doses in storage across the country - but these shots are due to expire in less than six months.

UK Government report finds “alarming” COVID impact in South Asians

The first wave saw minority ethnicities hit harder than white people, but in the second wave things are improving - with the exception of an "alarming" COVID impact in South Asians, specifically Bangladeshis and Pakistanis.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders